Officials confirm the appointment of Australia's chief health economist

February 16, 2024 Latest News BioPharma News of the Day

This is a preview of subscriber content

Subscribe now to continue reading.

Senior health department officials have confirmed the appointment of a new 'chief health economist' and confirmed that they will play a role in implementing the outcomes of the Health Technology Assessment Review. …

Subscribe now to continue reading.

Latest Video

Health Department clarifies PBAC plan after confusion over paediatric access to biologics
December 10, 2025 - Latest News
If this was the plan, why wasn't it included in the response to questions last week?
December 10, 2025 - Latest News
Immutep strikes major licensing deal with Dr. Reddy’s to commercialise novel cancer immunotherapy
December 9, 2025 - Australian Biotech
Pfizer’s high-stakes sprint to build momentum in century-defining market
December 11, 2025 - Latest News
Mayne Pharma rejects Cosette’s attempt to terminate scheme deal
December 10, 2025 - Latest News

Officials confirm the appointment of Australia's chief health economist

This is a preview of subscriber content

Latest Video

Most Read

Health Department clarifies PBAC plan after confusion over paediatric access to biologics

If this was the plan, why wasn't it included in the response to questions last week?

Immutep strikes major licensing deal with Dr. Reddy’s to commercialise novel cancer immunotherapy

Pfizer’s high-stakes sprint to build momentum in century-defining market

Mayne Pharma rejects Cosette’s attempt to terminate scheme deal

New Stories

Medicines Australia gains a new voice with Vertex joining the association

BMS marks 70 years in Australia with renewed commitment to innovation and access

Opportunity cost is a moral and ethical question when it involves travel, tickets, or treating sick children

Pfizer’s high-stakes sprint to build momentum in century-defining market

Mayne Pharma rejects Cosette’s attempt to terminate scheme deal

TGA clears the way for LTR Pharma’s Phase 2 Study of SPONTAN

OncoSil announces first UK patient treated with its pancreatic cancer treatment

Sign In

Officials confirm the appointment of Australia's chief health economist

This is a preview of subscriber content

Latest Video

Most Read

Health Department clarifies PBAC plan after confusion over paediatric access to biologics

If this was the plan, why wasn't it included in the response to questions last week?

Immutep strikes major licensing deal with Dr. Reddy’s to commercialise novel cancer immunotherapy

Pfizer’s high-stakes sprint to build momentum in century-defining market

Mayne Pharma rejects Cosette’s attempt to terminate scheme deal

Follow Us

New Stories

Medicines Australia gains a new voice with Vertex joining the association

BMS marks 70 years in Australia with renewed commitment to innovation and access

Opportunity cost is a moral and ethical question when it involves travel, tickets, or treating sick children

Pfizer’s high-stakes sprint to build momentum in century-defining market

Mayne Pharma rejects Cosette’s attempt to terminate scheme deal

TGA clears the way for LTR Pharma’s Phase 2 Study of SPONTAN

OncoSil announces first UK patient treated with its pancreatic cancer treatment